在APP的突变保护阿尔茨海默病和与年龄相关的认知衰退
Thorlakur Jonsson1, Jasvinder K Atwal, Stacy Steinberg
1deCODE genetics, Sturlugata 8, 101 Reykjavik, Iceland.
Nature
|July 18, 2012
概括
在粉样β前体蛋白 (APP) 基因中发现了一种特定的基因突变,A673T,可以预防阿尔茨海默病. 这一发现为减少认知衰退提供了一个新的治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 在西方国家,痴呆症影响了超过5%的60岁以上的人群,阿尔茨海默氏症占病例的三分之二.
- 阿尔茨海默病的患病率随着年龄的增长而显著增加,在65岁后每五年几乎翻一番.
- 识别影响阿尔茨海默病风险的遗传因素对于开发有效干预措施至关重要.
研究的目的:
- 调查粉样β前体蛋白 (APP) 基因中低频编码变异对它们对阿尔茨海默病风险的影响.
- 为了确定APP基因中的特定突变,这些突变可能会对阿尔茨海默病产生保护.
主要方法:
- 对1795名冰岛人进行了全基因组测序,以分析APP基因中的编码变异.
- 在体外实验中进行了实验,以评估已识别的突变对粉样形成的功能影响.
主要成果:
- 在APP基因中发现了一种特定的编码突变,A673T.
- A673T突变显示出对阿尔茨海默病和与年龄相关的认知能力下降有显著的保护作用.
- 实验室研究表明,A673T可以减少大约40%的氨基类的形成.
结论:
- A673T突变提供了强有力的证据,表明减少APP的β分裂可以预防阿尔茨海默病.
- 抗阿尔茨海默病和一般认知衰退的A673T的保护机制可能涉及类似的途径.
- 这一发现支持开发针对APP处理的治疗策略,以预防和治疗阿尔茨海默病.
更多相关视频
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
7.7K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.4K
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Amnesia
950
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
950
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
